The lawsuit was brought against the FDA after the agency declared an end to the shortage that allowed pharmacies to sell compound versions of the popular weight loss drugs, but Eli Lilly said it ...

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

Jaxson Dart's final college pass was a 69-yard touchdown that got him chewed out by coach Lane Kiffin on the sideline.

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

From PBMs to abortion, there are plenty of health policy issues that will vie for the spotlight in 2025. For pharma marketers ...

Immunocore Holdings ( ) has provided an announcement. Immunocore Holdings has appointed Travis Coy as its new Executive Vice President, Chief Financial Officer, and Head of Corpor ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

The weight loss industry has become one of the most profitable and popular sectors in healthcare. It will help Eli Lilly ...

We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments’ Substack by Kontra. In this article, we ...

What a year! What do you think was the most important news in the United States in 2024? This list probably doesn’t reflect that. Rather, it shows what you, the readers, were looking at on ...

Check out all our end-of-year content—the latest Heart Sounds podcast reviews the reporters’ own favorite stories for 2024, ...

By itself, it’s not enough, but body mass index has years of evidence behind it and still has a place in clinical assessments ...